Suppr超能文献

原发性胆汁性胆管炎与自身免疫性肝炎重叠综合征的特征及住院结局

Characteristics and Inpatient Outcomes of Primary Biliary Cholangitis and Autoimmune Hepatitis Overlap Syndrome.

作者信息

Jiang Yi, Xu Bing-Hong, Rodgers Brandon, Pyrsopoulos Nikolaos

机构信息

Department of Medicine, Rutgers New Jersey Medical School, Newark, New Jersey, USA.

Liver Center & Center for Asian Health, RWJBH-Saint Barnabas Medical Center, Florham Park, New Jersey, USA.

出版信息

J Clin Transl Hepatol. 2021 Jun 28;9(3):392-398. doi: 10.14218/JCTH.2021.00008. Epub 2021 Mar 11.

Abstract

BACKGROUND AND AIMS

Primary biliary cholangitis (PBC) and autoimmune hepatitis (AIH) are hepatobiliary diseases of presumed immune-mediated origin that have been shown to overlap. The aim of this retrospective trial was to use national data to examine the characteristics and outcomes of patients hospitalized with overlapping PBC and AIH (PBC/AIH).

METHODS

The National Inpatient Sample was used to identify hospitalized adult patients with PBC, AIH, and PBC/AIH from 2010 to 2014 by International Classification of Diseases-Ninth Edition Revision codes; patients with hepatitis B virus and hepatitis C virus infection were excluded. Primary outcomes measures were in-hospital outcomes that included mortality, respiratory failure, septic shock, length of stay, and total hospital charges. Secondary outcomes were the clinical characteristics of PBC/AIH, including the comorbid extrahepatic autoimmune disease pattern and complications of cirrhosis.

RESULTS

A total of 3,478 patients with PBC/AIH were included in the study. PBC/AIH was associated with higher rates of Sjögren's syndrome (<0.001; <0.001), lower rates of Crohn's disease (<0.05; <0.05), and higher rates of cirrhosis-related complications when compared to PBC or AIH alone. There were similar rates of mortality between the PBC/AIH, PBC, and AIH groups. The PBC/AIH group had higher rates of septic shock when compared to the PBC group (<0.05) and AIH group (<0.05) after adjusting for possible confounders.

CONCLUSIONS

PBC/AIH is associated with a lower rate of Crohn's disease, a higher rate of Sjögren's syndrome, higher rates of cirrhosis-related complications, and significantly increased risk of septic shock compared to PBC and AIH individually.

摘要

背景与目的

原发性胆汁性胆管炎(PBC)和自身免疫性肝炎(AIH)是推测由免疫介导的肝胆疾病,已显示二者存在重叠。这项回顾性试验的目的是利用全国数据研究重叠性PBC和AIH(PBC/AIH)住院患者的特征及转归。

方法

使用全国住院患者样本,通过国际疾病分类第九版修订本编码,识别2010年至2014年住院的成年PBC、AIH及PBC/AIH患者;排除乙型肝炎病毒和丙型肝炎病毒感染患者。主要结局指标为住院结局,包括死亡率、呼吸衰竭、感染性休克、住院时间及总住院费用。次要结局为PBC/AIH的临床特征,包括合并的肝外自身免疫性疾病模式及肝硬化并发症。

结果

本研究共纳入3478例PBC/AIH患者。与单独的PBC或AIH相比,PBC/AIH与干燥综合征发生率较高(<0.001;<0.001)、克罗恩病发生率较低(<0.05;<0.05)及肝硬化相关并发症发生率较高相关。PBC/AIH组、PBC组和AIH组之间的死亡率相似。在调整可能的混杂因素后,PBC/AIH组与PBC组(<0.05)和AIH组(<0.05)相比,感染性休克发生率较高。

结论

与单独的PBC和AIH相比,PBC/AIH与较低的克罗恩病发生率、较高的干燥综合征发生率、较高的肝硬化相关并发症发生率及感染性休克风险显著增加相关。

相似文献

1
Characteristics and Inpatient Outcomes of Primary Biliary Cholangitis and Autoimmune Hepatitis Overlap Syndrome.
J Clin Transl Hepatol. 2021 Jun 28;9(3):392-398. doi: 10.14218/JCTH.2021.00008. Epub 2021 Mar 11.
5
Autoimmune hepatitis - primary biliary cholangitis overlap syndrome. Long-term outcomes of a retrospective cohort in a university hospital.
Gastroenterol Hepatol. 2018 Nov;41(9):544-552. doi: 10.1016/j.gastrohep.2018.05.019. Epub 2018 Jul 13.
8
Comprehensive assessment of ECM turnover using serum biomarkers establishes PBC as a high-turnover autoimmune liver disease.
JHEP Rep. 2020 Sep 3;3(1):100178. doi: 10.1016/j.jhepr.2020.100178. eCollection 2021 Feb.

引用本文的文献

2
Trends and hotspots in autoimmune hepatitis research: based on bibliometric analysis.
Hereditas. 2025 Jul 1;162(1):115. doi: 10.1186/s41065-025-00477-6.
3
Overlap syndromes in autoimmune liver disease: a review.
Transl Gastroenterol Hepatol. 2025 Apr 15;10:33. doi: 10.21037/tgh-24-140. eCollection 2025.
8
Clinical significance of serum antinuclear antibodies in patients with autoimmune hepatitis and comorbidity.
Clin Exp Med. 2023 Nov;23(7):3453-3463. doi: 10.1007/s10238-023-01094-1. Epub 2023 May 23.
9
KASL clinical practice guidelines for management of autoimmune hepatitis 2022.
Clin Mol Hepatol. 2023 Jul;29(3):542-592. doi: 10.3350/cmh.2023.0087. Epub 2023 May 3.
10
Autoimmune hepatitis and primary biliary cholangitis overlap syndrome after COVID-19.
Autops Case Rep. 2023 Mar 10;13:e2023422. doi: 10.4322/acr.2023.422. eCollection 2023.

本文引用的文献

1
CTHRC1 expression in primary biliary cholangitis.
J Dig Dis. 2019 Jul;20(7):371-376. doi: 10.1111/1751-2980.12791. Epub 2019 Jul 1.
2
Burden of Primary Biliary Cholangitis Among Inpatient Population in the United States.
Hepatol Commun. 2019 Jan 28;3(3):356-364. doi: 10.1002/hep4.1314. eCollection 2019 Mar.
3
Extrahepatic autoimmunity in autoimmune liver disease.
Eur J Intern Med. 2019 Jan;59:1-7. doi: 10.1016/j.ejim.2018.10.014. Epub 2018 Oct 22.
4
Primary Biliary Cholangitis and Autoimmune Hepatitis.
Surg Pathol Clin. 2018 Jun;11(2):329-349. doi: 10.1016/j.path.2018.02.010.
5
Hospitalizations for Autoimmune Hepatitis Disproportionately Affect Black and Latino Americans.
Am J Gastroenterol. 2018 Feb;113(2):243-253. doi: 10.1038/ajg.2017.456. Epub 2018 Jan 30.
6
Pathogenesis of biliary fibrosis.
Biochim Biophys Acta Mol Basis Dis. 2018 Apr;1864(4 Pt B):1279-1283. doi: 10.1016/j.bbadis.2017.07.026. Epub 2017 Jul 25.
7
Why Doesn't Primary Biliary Cholangitis Respond to Immunosuppressive Medications?
Curr Hepatol Rep. 2017;16(2):119-123. doi: 10.1007/s11901-017-0345-y. Epub 2017 Apr 27.
9
Extrahepatic Autoimmune Diseases in Patients with Autoimmune Liver Diseases: A Phenomenon Neglected by Gastroenterologists.
Gastroenterol Res Pract. 2017;2017:2376231. doi: 10.1155/2017/2376231. Epub 2017 Jan 16.
10
Novel therapeutics for primary biliary cholangitis: Toward a disease-stage-based approach.
Autoimmun Rev. 2016 Sep;15(9):870-6. doi: 10.1016/j.autrev.2016.07.003. Epub 2016 Jul 6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验